CLDX Stock | News | Quote | Stock Forum | Saturday, November

New Post Public Reply Private Reply Replies (0) Message Board
Langan
Celldex Therapeutics, Inc. CLDX Company Overview 

Stock Message Board http://investorshangout.com/search?q=CLDX&...mp;yt1=Go!

Last Updated: Saturday, November 2, 2013 10:11:04 AM

Celldex Therapeutics, Inc. CLDX Current Price and Quotes
Last Price 22.62
Previous Close
22.90
Open
22.86

Daily Range
23.29 - 22.20
52wk Range
38.84 - 5.02

Volume
2,075,485
Dividend
N/A

Average Vol (3m)
2,655,692
Yield
N/A

Celldex Therapeutics, Inc. CLDX
Company Information
119 Fourth Avenue
Needham, MA 02494

Website: http://www.avantimmune.com
Phone: (781) 433-0771

Celldex Therapeutics, Inc. CLDX
Not Available

Celldex Therapeutics, Inc. CLDX
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Latest Report Jun 30, 2013 10-Q
CIK 0000744218
Fiscal Year End 12/31
OTC Marketplace Not Available
Profile Data
SIC - Industry Classification Not Available
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Notes
Formerly=AVANT Immunotherapeutics, Inc. until 10-2008
Formerly=T Cell Sciences, Inc. until 8-98
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Celldex Therapeutics, Inc. CLDX
CLDX Security Details
Share Structure
Market Value1 $1,899,975,454 a/o Nov 01, 2013
Shares Outstanding 80,987,871 a/o Jul 29, 2013
Float Not Available
Authorized Shares Not Available
Par Value  0.001
Shareholders
Shareholders of Record 634 a/o Mar 05, 2009
Security Notes
New Issue=5-86 2,800,000 shs in units (4 shs Com & 1 Warr 5-15-91) at $16 per unit by Allen & Co., Inc
Latest Addt'l Issue=8-96 5,000,000 shs at $2.1875 by Genesis Merchant Group Securities
Capital Change=shs decreased by 1 for 12 split. Pay date=03/10/2008.
Short Selling Data
Short Interest 4,722,540 (3.09%)
Nov 30, 2010
Significant Failures to Deliver  No
Transfer Agent(s)
Computershare Investor Services LLC

Celldex Therapeutics, Inc. CLDX Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 11,202 9,265 46,793 15,180
Cost of Revenue - - - -
Gross Profit 11,202 9,265 46,793 15,180
Operating Expenses
Research and Development 47,398 32,439 27,650 26,169
Sales, General and Admin. 10,016 9,193 10,378 17,119
Non-Recurring Items 10,775 9,119 12,077 8,397
Other 1,090 1,913 3,143 949
Operating Income (58,077) (43,399) (6,455) (36,850)
Income From Continuing Operations
Add'l Income/Expense Items 530 396 5,259 852
Earnings Before Interest and Tax (57,547) (43,003) (1,196) (36,602)
Interest Expense 1,576 1,796 1,337 452
Earnings Before Tax (59,123) (44,799) (2,533) (37,054)
Income Tax - - - (529)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (59,123) (44,799) (2,533) (36,525)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (59,123) (44,799) (2,533) (36,525)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (59,123) (44,799) (2,533) (36,525)

Celldex Therapeutics, Inc. CLDX Recent News


Oct 23, 2013 Financial Results, Regulatory Approvals, Stock Price Movements and Strategic Collaborations - Research Report on Pfizer, Stryker, Agilent Technologies, Celldex Therapeutics, and Novo Nordisk
Oct 22, 2013 Critical Alerts For Intel, SouFun, Celldex, Total SA, and SAP Released By InvestorsObserver
Oct 21, 2013 Celldex Therapeutics Announces Upcoming Data Presentations at the Society for Immunotherapy of Cancer and Society of Neuro-Oncology Annual Meetings
Oct 9, 2013 TSLA, HIMX, AGEN and CLDX added to Nasdaq Active Stock Watch List at EPR
Oct 3, 2013 Cellular Biomedicine Has Multiple Near-Term Catalysts
Sep 26, 2013 Celldex Therapeutics Announces Upcoming Presentation at the Leerink Swann Rare Disease Roundtable
Sep 26, 2013 Regulatory Approvals, Positive Stock Price Movements, Optimistic Clinical Data, and New Launches and Contracts - Research Report on Johnson & Johnson, Celldex, Isis, Actavis, and Centene
Sep 24, 2013 FSLR, LINE, GERN and CLDX added to NASDAQ Active Stock Watch List at EPR
Sep 20, 2013 Critical Alerts For Stratasys, Clovis Oncology, Sears, Mondelez, and Celldex Therapeutics Released By InvestorsObserver
Aug 20, 2013 Critical Alerts For LinkedIn, Priceline, Celldex, PetSmart, and Ross Stores Released By InvestorsObserver

12next >

CLDX Celldex Therapeutics, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=CLDX&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/CLDX/quote
Stock Chart http://www.otcmarkets.com/stock/CLDX/chart
Company Info http://www.otcmarkets.com/stock/CLDX/company-info
Recent News http://www.otcmarkets.com/stock/CLDX/news
Financials http://www.otcmarkets.com/stock/CLDX/financials
Filings and Disclosure http://www.otcmarkets.com/stock/CLDX/filings
Short Sales http://www.otcmarkets.com/stock/CLDX/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/CLDX/insider-transactions
Research Reports http://www.otcmarkets.com/stock/CLDX/research
Summary http://finance.yahoo.com/q?s=CLDX
Historical Prices http://finance.yahoo.com/q/hp?s=CLDX+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=CLDX
Basic Chart http://finance.yahoo.com/q/bc?s=CLDX+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=CLDX+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=CLDX+Headlines
Press Releases http://finance.yahoo.com/q/p?s=CLDX+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=CLDX+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=CLDX+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=CLDX+Industry
Major Holders http://finance.yahoo.com/q/mh?s=CLDX+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=CLDX+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=CLDX+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=CLDX
Balance Sheet http://finance.yahoo.com/q/bs?s=CLDX
Cash Flow http://finance.yahoo.com/q/cf?s=CLDX+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/CLDX
Market Watch http://www.marketwatch.com/investing/stock/CLDX
Bloomberg http://www.bloomberg.com/quote/CLDX:US
Morningstar http://quotes.morningstar.com/stock/s?t=CLDX
Bussinessweek http://investing.businessweek.com/research/st...icker=CLDX
Barchart http://www.barchart.com/quotes/stocks/CLDX
OTC Short Report http://otcshortreport.com/index.php?index=CLDX
Investopedia http://www.investopedia.com/markets/stocks/CLDX/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bizzdesign Tops Gartner’s 2026 Enterprise Architecture List

Updated Category News Views 100

Enterprise Architecture’s Silent Backbone Sometimes it's the quiet operators like Bizzdesign that hijack the spotlight after years of steady steering. With the latest nod from Gartner, Bizzdesign is clearly on a tear in the enterprise architecture domain. In their 2026 Critical Capabilities report, Bizzdesign's products—Horizzon, Alfabet, and Hopex—secured top spots...

Continue Reading
Ranger and Smith Unveil Tea-Infused Chocolate Bar

Updated Category News Views 38

Fresh Collaborations in Portland's Culinary Scene Ah, the sweet crossover in Portland's food scene is once again in the spotlight with a new entry that's sure to titillate taste buds. Ranger Chocolate Co. and Steven Smith Teamaker are at it again, rolling out a delectable creation that merges the poetic elegance of tea with the indulgent richness of chocolate. Welcome,...

Continue Reading
Roche Delivers Endotrophin Assay to Nordic Bioscience Lab

Updated Category News Views 52

Roche Opens New Frontier in Diagnostic Biomarkers Get ready to chew on this: Roche Diagnostics is bringing something new to Nordic Bioscience's CLIA lab. They're offering up their Endotrophin research prototype assay on the cobas® e801 Analyzer. Now, what does this mean for the scientific world? Well, it might just shake things up for those battling cardiovascular and...

Continue Reading
Biel Crystal Solidifies Position as Key iPhone UTG Supplier

Updated Category News Views 71

Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 301

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
Tips for a Dementia-Friendly Thanksgiving Gathering

Updated Category News Views 36

Thanksgiving's supposed to bring families round the table, right? But toss a few knuckleheads together, add a pinch of dementia, and suddenly it's like throwing dice at a craps table. The American Speech-Language-Hearing Association (ASHA) reckons they've got tricks up their sleeve to keep the holiday from unraveling. The Thanksgiving Reality Check The hustle, bustle, and...

Continue Reading
Bank Hapoalim's Q3 2026: Steady Growth Amid Challenges

Updated Category News Views 105

Digging Deep into Hapoalim's Recent Results Now ain't this a turn of events? Bank Hapoalim rolls out its numbers for Q3 2026, and while there's no confetti dropping from the ceiling, the numbers are telling their own story. Net profit comes to a solid NIS 2,364 million, but we're looking at a landscape that's not all rose-tinted today. The bank's managed to pull off...

Continue Reading
Portillo's Faces Legal Heat: Investor Class Action Filed

Updated Category News Views 23

What’s Eating Portillo's? Ah, once upon a misstep in the land of promising expansion, now we have Portillo's Inc. (NASDAQ: PTLO) neck-deep in legal hot water. Those golden fries and famous sandwiches somehow didn't pave the way for stockholder bliss. Why the turmoil? On an ordinary November morning, the DJS Law Group made it clear: They're rallying the troops for a...

Continue Reading
The Melt Grabs Top Spot in Burger Ratings War

Updated Category News Views 5

Burger Battle: The Melt Claims Victory When you're in the cutthroat world of fast-casual dining, grabbing the top spot on any list is no small potatoes. The Melt did just that, snatching the title of America’s Highest-Rated Burger Spot. Based on an in-depth analysis of Google and Yelp reviews, folks have spoken, loud and clear, over the past two years. It's a world...

Continue Reading
ICEYE Launches Gen5 SAR Satellite for Unrivaled Clarity

Updated Category News Views 92

Well, if you've been sleeping under a rock and missed the news, ICEYE just dropped another bombshell in the satellite biz. Gen5 is the name of the game, and it's claiming the spotlight for its razor-sharp imaging prowess. Now, we're talking about a satellite that supposedly snaps pictures with a resolution as fine as 11 cm. That's like spotting a flea on a dog's back from...

Continue Reading

Top 5 Most Recently Viewed Articles

Customers Bancorp, Inc. Faces Class Action Lawsuit

Updated Category News Views 179

Introduction to the Class Action Lawsuit Against Customers Bancorp Recently, Customers Bancorp, Inc. found itself at the center of a significant legal challenge. A securities class action lawsuit has been initiated in federal court on behalf of investors who purchased or acquired shares of Customers Bancorp, Inc. (NYSE: CUBI) during a specific time frame. This action...

Continue Reading
Projected Growth in the Aluminum Beverage Can Industry

Updated Category News Views 238

Exploring the Future of the Aluminum Beverage Can Market As the aluminum beverage can industry steers toward a monumental future, it's evident that the market has grown significantly, evolving to meet the rising demand for sustainable and practical packaging solutions. With a valuation of US$ 36.95 billion in 2024, projections indicate a remarkable increase to US$ 61.12...

Continue Reading
Cybersecurity Initiative Launches for Global Nonprofit Protection

Updated Category News Views 87

Global Leaders Unite for Nonprofit Cybersecurity Influential figures from various sectors gathered at the historic Peace Palace to advocate for better cybersecurity within the nonprofit sector. This initiative, known as 'BEYOND125, Securing Our World's Digital Future,' is focused on tackling significant cybersecurity challenges faced by millions of organizations around...

Continue Reading
Guarda Wallet's Gas-Free USDT Revolution on Tron

Updated Category News Views 44

The Frictionless Future of USDT on the Tron Network You know, it seems like every few months we hear about some innovation that's going to 'revolutionize' crypto transactions. But here's something that's actually shifting the gears—a practical workaround for a typical problem faced by the average Joe trading in stablecoins. Welcome to Guarda Wallet's gas-free...

Continue Reading
Ultragenyx and Mereo BioPharma Stocks Face Significant Decline

Updated Category News Views 130

Overview of Current Situation Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) and Mereo BioPharma Group plc (NASDAQ: MREO) saw their stock values significantly drop recently, causing concern among investors. The decline comes in light of new developments from their ongoing clinical trials for a drug targeting a rare genetic disorder. What Unfolded? The duo announced updates...

Continue Reading